You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 4, April 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chronic Idiopathic Axonal Polyneuropathy and Successful Aging of the Peripheral Nervous System

Arch Neurol. 2002;59:520-522.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN THIS ISSUE OF THE ARCHIVES, Vrancken and colleagues1 from the University Medical Center in Utrecht, the Netherlands, further define the clinical characteristics of chronic idiopathic axonal polyneuropathy (CIAP). These unclassified sensory-predominant polyneuropathies are common in middle to late adulthood and have been an ongoing interest of the Utrecht group2 as well as of others.3 The age of onset for CIAP tends to be in the sixth decade of life or later. A large majority of patients with CIAP present with foot discomfort. Symptoms and signs are length dependent and progress slowly, and electrophysiologic and histologic data are consistent with a primarily axonal injury. Once identifiable causes for polyneuropathy have been excluded, patient management usually focuses on the treatment of neuropathic pain.

In their current study, Vrancken et al1 examine 2 separate but related issues. The first question addressed is whether the prognosis of CIAP differs for those individuals who . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.